For companies preparing to initiate an public offering, stringent adherence to Good Manufacturing Practices (GMP) is absolutely critical. Regulatory bodies, such as the FDA, commonly scrutinize applicant's production processes to confirm product quality and patient safety. Failure to demonstrate robust GMP compliance can result in hindrances in the